Inter Pharma PCL (BKK:IP)

Market Cap	1.50B
Revenue (ttm)	1.91B
Net Income (ttm)	37.28M
Shares Out	605.34M
EPS (ttm)	0.06
PE Ratio	40.27
Forward PE	n/a
Dividend	0.02 (0.88%)
Ex-Dividend Date	n/a

Volume	1,846,688
Average Volume	1,284,424
Open	2.420
Previous Close	2.420
Day's Range	2.400 - 2.500
52-Week Range	2.020 - 6.950
Beta	0.61
RSI	51.20
Earnings Date	Feb 28, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand. It operates through three: Human Healthcare, Animal Healthcare, and Hospital segments. The company offers human, anti-aging, and human products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; functional foods and drinks; and pharmaceutical products; It also provi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.